Sign in
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Wednesday, September 24, 2025
Advertising
About Us
Subscribe to Newsletter
Facebook
Twitter
Youtube
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Search
Home
Pharma
Pharma
Pharma
FDA Grants Priority Review to ENHERTU and Pertuzumab Combination for First-Line Treatment of HER2-Positive Metastatic Breast Cancer
Life Sciences Times
-
September 24, 2025
Pharma
Actio Biosciences Doses First Participant in Phase 1 Trial of ABS-1230 for KCNT1-Related Epilepsy
Life Sciences Times
-
September 23, 2025
Pharma
FDA Issues Complete Response Letter for Scholar Rock’s Apitegromab, Citing Catalent Facility Observations
Life Sciences Times
-
September 23, 2025
Pharma
Vertex Teams Up with Jayson Tatum to Highlight JOURNAVX, a Non-Opioid Pain Medicine
Life Sciences Times
-
September 23, 2025
Pharma
KalVista Wins EU, Swiss Approvals for EKTERLY, First Oral On-Demand Therapy for Hereditary Angioedema
Life Sciences Times
-
September 19, 2025
Pharma
Ellipses Pharma Announces FDA Approval of IND Application for EP0042 for Patients With Acute Myeloid Leukaemia
Life Sciences Times
-
February 1, 2023
0
Pharma
Virpax Pharmaceuticals Engages New England Investors to Direct Licensing Strategy for Envelta™ in China
Life Sciences Times
-
January 31, 2023
0
Pharma
Stemline Therapeutics, a Subsidiary of Menarini Group, Receives U.S. FDA Approval for ORSERDU™ (elacestrant) as the First and Only Treatment Specifically Indicated for Patients...
Life Sciences Times
-
January 30, 2023
0
Pharma
Spesolimab meets primary and key secondary endpoint for prevention of generalized pustular psoriasis flares
Life Sciences Times
-
January 30, 2023
0
Pharma
Aptar Pharma Launches First Metal-Free Nasal Spray Pump, Meeting Growing Need for Highly Recyclable Packaging
Life Sciences Times
-
January 30, 2023
0
Pharma
Legend Biotech Announces Phase 3 CARTITUDE-4 Study of CARVYKTI® (ciltacabtagene autoleucel) Has Met Its Primary Endpoint in the Treatment of Patients with Relapsed and...
Life Sciences Times
-
January 27, 2023
0
Pharma
Bristol Myers Squibb Receives Positive CHMP Opinion for Reblozyl® (luspatercept) for Adult Patients with Anemia-Associated, Non-Transfusion-Dependent (NTD) Beta Thalassemia
Life Sciences Times
-
January 27, 2023
0
Pharma
BRUKINSA® (zanubrutinib) Receives Marketing Authorization for Chronic Lymphocytic Leukemia (CLL) and Marginal Zone Lymphoma (MZL) in Great Britain by MHRA
Life Sciences Times
-
January 19, 2023
0
Pharma
Amylyx Pharmaceuticals Announces Exclusive AMX0035 Distribution Agreement with Israel-Based Neopharm
Life Sciences Times
-
January 17, 2023
0
Pharma
Lantern Pharma Receives Pre-IND Feedback from the FDA, Clearing a Path for Drug Candidate LP-184’s Phase 1 Clinical Trial in Q2 2023
Life Sciences Times
-
January 17, 2023
0
Pharma
Results of the First Post-Commercial Utilization Review of JELMYTO® Provide New Evidence that Reinforces its Efficacy and Safety in Patients with Low-Grade Upper Tract...
Life Sciences Times
-
January 11, 2023
0
Pharma
Neurotech Pharmaceuticals, Inc. Expands Executive Team with the Appointment of Scott Hunter as Chief Commercial Officer
Life Sciences Times
-
January 10, 2023
0
1
...
31
32
33
...
80
Page 32 of 80
Most Read
Future Family Names Alden Romney CEO, Founder Claire Tomkins Transitions to Executive Chair
September 24, 2025
Groups Names Cooper Zelnick as CEO to Lead Next Phase of Growth in Value-Based Addiction Care
September 24, 2025
MEDiC Life Sciences Acquires Clinical-Stage Oncology Program, Leveraging Biomarker Platform for Precision Medicine
September 24, 2025
AVS Expands with New Waltham Headquarters as It Prepares for U.S. Launch of PULSE IVL System
September 24, 2025